tiprankstipranks
Recursion Pharmaceuticals (RXRX)
NASDAQ:RXRX
RXRX
Recursion Pharmaceuticals
RESEARCH TOOLSreports
Want to see RXRX full AI Analyst Report?

Recursion Pharmaceuticals (RXRX) Revenue

4,652 Followers
StatisticsMarket CapRevenue

Recursion Pharmaceuticals Revenue

Recursion Pharmaceuticals had a revenue of 7.67M in the quarter ending Jun 30, 2026, with 18.51%. This bring the company's revenue in the last twelve months to 54.85M, Increased -17.25%. In the fiscal year ending Dec 31, 2025, Recursion Pharmaceuticals had annual revenue of 74.68M with 26.92% growth.
Revenue (ttm)
54.85M
Revenue Growth
-15.08%
P/S Ratio
26.07
Revenue/Employee
$124,468
Employees
600
Market Cap
$1.95B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
74.68M15.84M+26.92%
Dec 31, 2024
58.84M14.96M+34.10%
Dec 31, 2023
43.88M4.20M+10.57%
Dec 31, 2022
39.68M29.68M+296.81%
Dec 31, 2021
10.00M6.59M+193.00%
Dec 31, 2020
3.41M1.70M+99.47%
Dec 31, 2019
1.71M――